Phenogen Sciences, Inc.
BioTech/Drugs - Charlotte, NC, US
Phenogen Sciences, Inc. Employees
Phenogen Sciences, Inc. Details
Phenogen Sciences, Inc., a US division of Australia-based Genetic Technologies Limited, was established in 2010 as a global expansion strategy of the company's oncology and cancer management diagnostics business. As a pioneer in personalized healthcare, Phenogen Sciences offers novel predictive testing and risk assessment tools that help physicians proactively manage the health of their patients. Phenogen's lead product, BREVAGenplus™ is the first clinically validated predictive risk test that combines genetic and clinical data to categorize a woman's personal risk of developing breast cancer.Its parent company, Genetic Technologies Limited (NASDAQ: GENE) is based in Melbourne, Australia. For more than 20 years, the company has provided laboratory services in molecular diagnostics and was an early pioneer in recognizing important new applications for ‘non-coding' DNA (Deoxyribonucleic Acid). The company has since been granted patents in 24 countries around the world.
Phenogen Sciences, Inc. Technologies
Email Providers
Outlook
Social Sharing
AddThis
Load Balancers
Nginx
Other
Mobile Friendly
Analytics and Tracking
Google Analytics